{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:37:10Z","timestamp":1794267430572,"version":"4.9.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41593-025-01873-x","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T10:11:13Z","timestamp":1738145473000},"page":"446-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["Oligodendrocytes in Alzheimer\u2019s disease pathophysiology"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0445-1621","authenticated-orcid":false,"given":"Shreeya","family":"Kedia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5329-192X","authenticated-orcid":false,"given":"Mikael","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"1873_CR1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"1873_CR2","unstructured":"GBD 2019 Dementia Forecasting Collaborators. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105\u2013e125 (2022)."},{"key":"1873_CR3","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe, D. J. & Hardy, J. The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO Mol. Med. 8, 595\u2013608 (2016).","journal-title":"EMBO Mol. Med."},{"key":"1873_CR4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr.","year":"2013","unstructured":"Jack, C. R. Jr. et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"1873_CR5","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007901","volume":"6","author":"AM Fagan","year":"2014","unstructured":"Fagan, A. M. et al. Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer\u2019s disease. Sci. Transl. Med. 6, 226ra230 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1873_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","volume":"23","author":"GB Frisoni","year":"2022","unstructured":"Frisoni, G. B. et al. The probabilistic model of Alzheimer disease: the amyloid hypothesis revised. Nat. Rev. Neurosci. 23, 53\u201366 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"1873_CR7","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/j.neuron.2023.04.018","volume":"111","author":"J Rollo","year":"2023","unstructured":"Rollo, J., Crawford, J. & Hardy, J. A dynamical systems approach for multiscale synthesis of Alzheimer\u2019s pathogenesis. Neuron 111, 2126\u20132139 (2023).","journal-title":"Neuron"},{"key":"1873_CR8","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.neuron.2023.05.031","volume":"111","author":"M Simons","year":"2023","unstructured":"Simons, M., Levin, J. & Dichgans, M. Tipping points in neurodegeneration. Neuron 111, 2954\u20132968 (2023).","journal-title":"Neuron"},{"key":"1873_CR9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper, B. & Karran, E. The cellular phase of Alzheimer\u2019s disease. Cell 164, 603\u2013615 (2016).","journal-title":"Cell"},{"key":"1873_CR10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","volume":"570","author":"H Mathys","year":"2019","unstructured":"Mathys, H. et al. Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570, 332\u2013337 (2019).","journal-title":"Nature"},{"key":"1873_CR11","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1016\/j.cell.2023.08.039","volume":"186","author":"H Mathys","year":"2023","unstructured":"Mathys, H. et al. Single-cell atlas reveals correlates of high cognitive function, dementia, and resilience to Alzheimer\u2019s disease pathology. Cell 186, 4365\u20134385 (2023).","journal-title":"Cell"},{"key":"1873_CR12","doi-asserted-by":"crossref","unstructured":"Chen, W. T. et al. Spatial transcriptomics and in situ sequencing to study Alzheimer\u2019s disease. Cell 182, 976\u2013991 (2020).","DOI":"10.1016\/j.cell.2020.06.038"},{"key":"1873_CR13","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00031.2018","volume":"99","author":"C Stadelmann","year":"2019","unstructured":"Stadelmann, C., Timmler, S., Barrantes-Freer, A. & Simons, M. Myelin in the central nervous system: structure, function, and pathology. Physiol. Rev. 99, 1381\u20131431 (2019).","journal-title":"Physiol. Rev."},{"key":"1873_CR14","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1126\/science.aaf6463","volume":"352","author":"S Marques","year":"2016","unstructured":"Marques, S. et al. Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system. Science 352, 1326\u20131329 (2016).","journal-title":"Science"},{"key":"1873_CR15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/s41591-018-0236-y","volume":"24","author":"AM Falcao","year":"2018","unstructured":"Falcao, A. M. et al. Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis. Nat. Med. 24, 1837\u20131844 (2018).","journal-title":"Nat. Med."},{"key":"1873_CR16","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/glia.23614","volume":"67","author":"S Timmler","year":"2019","unstructured":"Timmler, S. & Simons, M. Grey matter myelination. Glia 67, 2063\u20132070 (2019).","journal-title":"Glia"},{"key":"1873_CR17","doi-asserted-by":"crossref","unstructured":"Hill, R. A., Li, A. M. & Grutzendler, J. Lifelong cortical myelin plasticity and age-related degeneration in the live mammalian brain. Nat. Neurosci. 21, 683\u2013695 (2018).","DOI":"10.1038\/s41593-018-0120-6"},{"key":"1873_CR18","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41593-018-0121-5","volume":"21","author":"EG Hughes","year":"2018","unstructured":"Hughes, E. G., Orthmann-Murphy, J. L., Langseth, A. J. & Bergles, D. E. Myelin remodeling through experience-dependent oligodendrogenesis in the adult somatosensory cortex. Nat. Neurosci. 21, 696\u2013706 (2018).","journal-title":"Nat. Neurosci."},{"key":"1873_CR19","doi-asserted-by":"crossref","unstructured":"Fard, M. K. et al. BCAS1 expression defines a population of early myelinating oligodendrocytes in multiple sclerosis lesions. Sci. Transl. Med. 9, eaam7816 (2017).","DOI":"10.1126\/scitranslmed.aam7816"},{"key":"1873_CR20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1083\/jcb.201404154","volume":"206","author":"M Simons","year":"2014","unstructured":"Simons, M., Misgeld, T. & Kerschensteiner, M. A unified cell biological perspective on axon\u2013myelin injury. J. Cell Biol. 206, 335\u2013345 (2014).","journal-title":"J. Cell Biol."},{"key":"1873_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/35012083","volume":"405","author":"DE Bergles","year":"2000","unstructured":"Bergles, D. E., Roberts, J. D. B., Somogyi, P. & Jahr, C. E. Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus. Nature 405, 187\u2013191 (2000).","journal-title":"Nature"},{"key":"1873_CR22","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1073\/pnas.93.18.9887","volume":"93","author":"C Demerens","year":"1996","unstructured":"Demerens, C. et al. Induction of myelination in the central nervous system by electrical activity. Proc. Natl Acad. Sci. USA 93, 9887\u20139892 (1996).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1873_CR23","doi-asserted-by":"crossref","DOI":"10.1126\/science.1252304","volume":"344","author":"EM Gibson","year":"2014","unstructured":"Gibson, E. M. et al. Neuronal activity promotes oligodendrogenesis and adaptive myelination in the mammalian brain. Science 344, 1252304 (2014).","journal-title":"Science"},{"key":"1873_CR24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1146\/annurev-neuro-100719-093305","volume":"43","author":"PM Paez","year":"2020","unstructured":"Paez, P. M. & Lyons, D. A. Calcium signaling in the oligodendrocyte lineage: regulators and consequences. Annu. Rev. Neurosci. 43, 163\u2013186 (2020).","journal-title":"Annu. Rev. Neurosci."},{"key":"1873_CR25","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.celrep.2018.09.066","volume":"25","author":"TJ Chen","year":"2018","unstructured":"Chen, T. J. et al. In vivo regulation of oligodendrocyte precursor cell proliferation and differentiation by the AMPA-receptor subunit GluA2. Cell Rep. 25, 852\u2013861 (2018).","journal-title":"Cell Rep."},{"key":"1873_CR26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41593-023-01553-8","volume":"27","author":"J Li","year":"2024","unstructured":"Li, J., Miramontes, T. G., Czopka, T. & Monk, K. R. Synaptic input and Ca2+ activity in zebrafish oligodendrocyte precursor cells contribute to myelin sheath formation. Nat. Neurosci. 27, 219\u2013231 (2024).","journal-title":"Nat. Neurosci."},{"key":"1873_CR27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nn1162","volume":"7","author":"S-c Lin","year":"2004","unstructured":"Lin, S.-c & Bergles, D. E. Synaptic signaling between GABAergic interneurons and oligodendrocyte precursor cells in the hippocampus. Nat. Neurosci. 7, 24\u201332 (2004).","journal-title":"Nat. Neurosci."},{"key":"1873_CR28","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/nature04302","volume":"438","author":"R K\u00e1rad\u00f3ttir","year":"2005","unstructured":"K\u00e1rad\u00f3ttir, R., Cavelier, P., Bergersen, L. H. & Attwell, D. NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 438, 1162\u20131166 (2005).","journal-title":"Nature"},{"key":"1873_CR29","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/s41593-023-01426-0","volume":"26","author":"T-Y Lu","year":"2023","unstructured":"Lu, T.-Y. et al. Norepinephrine modulates calcium dynamics in cortical oligodendrocyte precursor cells promoting proliferation during arousal in mice. Nat. Neurosci. 26, 1739\u20131750 (2023).","journal-title":"Nat. Neurosci."},{"key":"1873_CR30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43920-w","volume":"14","author":"F Fiore","year":"2023","unstructured":"Fiore, F. et al. Norepinephrine regulates calcium signals and fate of oligodendrocyte precursor cells in the mouse cerebral cortex. Nat. Commun. 14, 8122 (2023).","journal-title":"Nat. Commun."},{"key":"1873_CR31","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/s41593-022-01052-2","volume":"25","author":"JK Knowles","year":"2022","unstructured":"Knowles, J. K. et al. Maladaptive myelination promotes generalized epilepsy progression. Nat. Neurosci. 25, 596\u2013606 (2022).","journal-title":"Nat. Neurosci."},{"key":"1873_CR32","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02719-2","volume":"9","author":"S Mitew","year":"2018","unstructured":"Mitew, S. et al. Pharmacogenetic stimulation of neuronal activity increases myelination in an axon-specific manner. Nat. Commun. 9, 306 (2018).","journal-title":"Nat. Commun."},{"key":"1873_CR33","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6905","volume":"374","author":"G Bonetto","year":"2021","unstructured":"Bonetto, G., Belin, D. & Karadottir, R. T. Myelin: a gatekeeper of activity-dependent circuit plasticity? Science 374, eaba6905 (2021).","journal-title":"Science"},{"key":"1873_CR34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1146\/annurev-neuro-080317-061853","volume":"41","author":"M Monje","year":"2018","unstructured":"Monje, M. Myelin plasticity and nervous system function. Annu. Rev. Neurosci. 41, 61\u201376 (2018).","journal-title":"Annu. Rev. Neurosci."},{"key":"1873_CR35","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.tins.2008.04.001","volume":"31","author":"RD Fields","year":"2008","unstructured":"Fields, R. D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 31, 361\u2013370 (2008).","journal-title":"Trends Neurosci."},{"key":"1873_CR36","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nature09614","volume":"468","author":"KA Nave","year":"2010","unstructured":"Nave, K. A. Myelination and support of axonal integrity by glia. Nature 468, 244\u2013252 (2010).","journal-title":"Nature"},{"key":"1873_CR37","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.celrep.2016.12.053","volume":"18","author":"N Snaidero","year":"2017","unstructured":"Snaidero, N. et al. Antagonistic functions of MBP and CNP establish cytosolic channels in CNS myelin. Cell Rep. 18, 314\u2013323 (2017).","journal-title":"Cell Rep."},{"key":"1873_CR38","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U Funfschilling","year":"2012","unstructured":"Funfschilling, U. et al. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485, 517\u2013521 (2012).","journal-title":"Nature"},{"key":"1873_CR39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443\u2013448 (2012).","journal-title":"Nature"},{"key":"1873_CR40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.neuron.2016.05.016","volume":"91","author":"AS Saab","year":"2016","unstructured":"Saab, A. S. et al. Oligodendroglial NMDA receptors regulate glucose import and axonal energy metabolism. Neuron 91, 119\u2013132 (2016).","journal-title":"Neuron"},{"key":"1873_CR41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41593-023-01558-3","volume":"27","author":"ZJ Looser","year":"2024","unstructured":"Looser, Z. J. et al. Oligodendrocyte\u2013axon metabolic coupling is mediated by extracellular K+ and maintains axonal health. Nat. Neurosci. 27, 433\u2013448 (2024).","journal-title":"Nat. Neurosci."},{"key":"1873_CR42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.cmet.2020.05.019","volume":"32","author":"C Mukherjee","year":"2020","unstructured":"Mukherjee, C. et al. Oligodendrocytes provide antioxidant defense function for neurons by secreting ferritin heavy chain. Cell Metab. 32, 259\u2013272 (2020).","journal-title":"Cell Metab."},{"key":"1873_CR43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s41593-022-01104-7","volume":"25","author":"M Kenigsbuch","year":"2022","unstructured":"Kenigsbuch, M. et al. A shared disease-associated oligodendrocyte signature among multiple CNS pathologies. Nat. Neurosci. 25, 876\u2013886 (2022).","journal-title":"Nat. Neurosci."},{"key":"1873_CR44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111189","volume":"40","author":"S Pandey","year":"2022","unstructured":"Pandey, S. et al. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell Rep. 40, 111189 (2022).","journal-title":"Cell Rep."},{"key":"1873_CR45","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s41593-022-01183-6","volume":"25","author":"T Kaya","year":"2022","unstructured":"Kaya, T. et al. CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging. Nat. Neurosci. 25, 1446\u20131457 (2022).","journal-title":"Nat. Neurosci."},{"key":"1873_CR46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41591-019-0695-9","volume":"26","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer\u2019s disease. Nat. Med. 26, 131\u2013142 (2020).","journal-title":"Nat. Med."},{"key":"1873_CR47","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-015-0376-7","volume":"12","author":"Y Haile","year":"2015","unstructured":"Haile, Y. et al. Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo. J. Neuroinflammation 12, 157 (2015).","journal-title":"J. Neuroinflammation"},{"key":"1873_CR48","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"1873_CR49","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11638-3","volume":"10","author":"L Kirby","year":"2019","unstructured":"Kirby, L. et al. Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination. Nat. Commun. 10, 3887 (2019).","journal-title":"Nat. Commun."},{"key":"1873_CR50","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer\u2019s disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"1873_CR51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41593-019-0372-9","volume":"22","author":"P Zhang","year":"2019","unstructured":"Zhang, P. et al. Senolytic therapy alleviates A\u03b2-associated oligodendrocyte progenitor cell senescence and cognitive deficits in an Alzheimer\u2019s disease model. Nat. Neurosci. 22, 719\u2013728 (2019).","journal-title":"Nat. Neurosci."},{"key":"1873_CR52","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"1873_CR53","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann, S. et al. The TREM2\u2013APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity 47, 566\u2013581 (2017).","journal-title":"Immunity"},{"key":"1873_CR54","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","volume":"173","author":"A Deczkowska","year":"2018","unstructured":"Deczkowska, A. et al. Disease-associated microglia: a universal immune sensor of neurodegeneration. Cell 173, 1073\u20131081 (2018).","journal-title":"Cell"},{"key":"1873_CR55","volume":"14","author":"H Park","year":"2023","unstructured":"Park, H. et al. Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice. Nat. Commun. 14, 802 (2023).","journal-title":"Nat. Commun."},{"key":"1873_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104511","volume":"90","author":"SJ Andrews","year":"2023","unstructured":"Andrews, S. J. et al. The complex genetic architecture of Alzheimer\u2019s disease: novel insights and future directions. EBioMedicine 90, 104511 (2023).","journal-title":"EBioMedicine"},{"key":"1873_CR57","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuron.2010.10.013","volume":"68","author":"L Bertram","year":"2010","unstructured":"Bertram, L., Lill, C. M. & Tanzi, R. E. The genetics of Alzheimer disease: back to the future. Neuron 68, 270\u2013281 (2010).","journal-title":"Neuron"},{"key":"1873_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt59","volume":"3","author":"RJ Bateman","year":"2011","unstructured":"Bateman, R. J. et al. Autosomal-dominant Alzheimer\u2019s disease: a review and proposal for the prevention of Alzheimer\u2019s disease. Alzheimers Res. Ther. 3, 1 (2011).","journal-title":"Alzheimers Res. Ther."},{"key":"1873_CR59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"1873_CR60","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","volume":"20","author":"A Serrano-Pozo","year":"2021","unstructured":"Serrano-Pozo, A., Das, S. & Hyman, B. T. APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 20, 68\u201380 (2021).","journal-title":"Lancet Neurol."},{"key":"1873_CR61","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass, C. & Selkoe, D. J. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid \u03b2-peptide. Nat. Rev. Mol. Cell Biol. 8, 101\u2013112 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1873_CR62","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuron.2015.11.013","volume":"89","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89, 37\u201353 (2016).","journal-title":"Neuron"},{"key":"1873_CR63","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"1873_CR64","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/nn.4160","volume":"18","author":"K Sharma","year":"2015","unstructured":"Sharma, K. et al. Cell type- and brain region-resolved mouse brain proteome. Nat. Neurosci. 18, 1819\u20131831 (2015).","journal-title":"Nat. Neurosci."},{"key":"1873_CR65","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1016\/j.cell.2023.08.005","volume":"186","author":"V Gazestani","year":"2023","unstructured":"Gazestani, V. et al. Early Alzheimer\u2019s disease pathology in human cortex involves transient cell states. Cell 186, 4438\u20134453 (2023).","journal-title":"Cell"},{"key":"1873_CR66","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/s41593-024-01730-3","volume":"27","author":"AO Sasmita","year":"2024","unstructured":"Sasmita, A. O. et al. Oligodendrocytes produce amyloid-\u03b2 and contribute to plaque formation alongside neurons in Alzheimer\u2019s disease model mice. Nat. Neurosci. 27, 1668\u20131674 (2024).","journal-title":"Nat. Neurosci."},{"key":"1873_CR67","doi-asserted-by":"crossref","first-page":"e3002727","DOI":"10.1371\/journal.pbio.3002727","volume":"22","author":"RM Rajani","year":"2024","unstructured":"Rajani, R. M. et al. Selective suppression of oligodendrocyte-derived amyloid \u03b2 rescues neuronal dysfunction in Alzheimer\u2019s disease. PLoS Biol. 22, e3002727 (2024).","journal-title":"PLoS Biol."},{"key":"1873_CR68","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamaneurol.2013.579","volume":"70","author":"RJ Guerreiro","year":"2013","unstructured":"Guerreiro, R. J. et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 70, 78\u201384 (2013).","journal-title":"JAMA Neurol."},{"key":"1873_CR69","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson, T. et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N. Engl. J. Med. 368, 107\u2013116 (2013).","journal-title":"N. Engl. J. Med."},{"key":"1873_CR70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuron.2017.02.042","volume":"94","author":"JD Ulrich","year":"2017","unstructured":"Ulrich, J. D., Ulland, T. K., Colonna, M. & Holtzman, D. M. Elucidating the role of TREM2 in Alzheimer\u2019s disease. Neuron 94, 237\u2013248 (2017).","journal-title":"Neuron"},{"key":"1873_CR71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2020.09.029","volume":"108","author":"JW Lewcock","year":"2020","unstructured":"Lewcock, J. W. et al. Emerging microglia biology defines novel therapeutic approaches for Alzheimer\u2019s disease. Neuron 108, 801\u2013821 (2020).","journal-title":"Neuron"},{"key":"1873_CR72","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1440-1789.2010.01127.x","volume":"30","author":"M Kaneko","year":"2010","unstructured":"Kaneko, M., Sano, K., Nakayama, J. & Amano, N. Nasu\u2013Hakola disease: the first case reported by Nasu and review: the 50th anniversary of Japanese Society of Neuropathology. Neuropathology 30, 463\u2013470 (2010).","journal-title":"Neuropathology"},{"key":"1873_CR73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-022-05534-y","volume":"613","author":"NB McNamara","year":"2023","unstructured":"McNamara, N. B. et al. Microglia regulate central nervous system myelin growth and integrity. Nature 613, 120\u2013129 (2023).","journal-title":"Nature"},{"key":"1873_CR74","doi-asserted-by":"crossref","unstructured":"Djannatian, M. et al. Myelination generates aberrant ultrastructure that is resolved by microglia. J. Cell Biol. 222, e202204010 (2023).","DOI":"10.1083\/jcb.202204010"},{"key":"1873_CR75","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.neuron.2024.05.018","volume":"112","author":"DAD Munro","year":"2024","unstructured":"Munro, D. A. D. et al. Microglia protect against age-associated brain pathologies. Neuron 112, 2732\u20132748 (2024).","journal-title":"Neuron"},{"key":"1873_CR76","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.neuron.2024.05.023","volume":"112","author":"JP Chadarevian","year":"2024","unstructured":"Chadarevian, J. P. et al. Therapeutic potential of human microglia transplantation in a chimeric model of CSF1R-related leukoencephalopathy. Neuron 112, 2686\u20132707 (2024).","journal-title":"Neuron"},{"key":"1873_CR77","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-022-05439-w","volume":"611","author":"JW Blanchard","year":"2022","unstructured":"Blanchard, J. W. et al. APOE4 impairs myelination via cholesterol dysregulation in oligodendrocytes. Nature 611, 769\u2013779 (2022).","journal-title":"Nature"},{"key":"1873_CR78","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jnen\/nlac054","volume":"81","author":"GW-Y Cheng","year":"2022","unstructured":"Cheng, G. W.-Y. et al. Apolipoprotein E \u03b54 mediates myelin breakdown by targeting oligodendrocytes in sporadic Alzheimer disease. J. Neuropathol. Exp. Neurol. 81, 717\u2013730 (2022).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1873_CR79","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","volume":"8","author":"G Saher","year":"2005","unstructured":"Saher, G. et al. High cholesterol level is essential for myelin membrane growth. Nat. Neurosci. 8, 468\u2013475 (2005).","journal-title":"Nat. Neurosci."},{"key":"1873_CR80","doi-asserted-by":"crossref","first-page":"e1002605","DOI":"10.1371\/journal.pbio.1002605","volume":"15","author":"N Camargo","year":"2017","unstructured":"Camargo, N. et al. Oligodendroglial myelination requires astrocyte-derived lipids. PLoS Biol. 15, e1002605 (2017).","journal-title":"PLoS Biol."},{"key":"1873_CR81","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/jamaneurol.2016.3232","volume":"74","author":"DC Dean 3rd","year":"2017","unstructured":"Dean, D. C. 3rd et al. Association of amyloid pathology with myelin alteration in preclinical Alzheimer disease. JAMA Neurol. 74, 41\u201349 (2017).","journal-title":"JAMA Neurol."},{"key":"1873_CR82","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/2013.jamaneurol.286","volume":"70","author":"HD Protas","year":"2013","unstructured":"Protas, H. D. et al. Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol. 70, 320\u2013325 (2013).","journal-title":"JAMA Neurol."},{"key":"1873_CR83","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","volume":"101","author":"EM Reiman","year":"2004","unstructured":"Reiman, E. M. et al. Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer\u2019s dementia. Proc. Natl Acad. Sci. USA 101, 284\u2013289 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1873_CR84","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0515-3","volume":"6","author":"SE Nasrabady","year":"2018","unstructured":"Nasrabady, S. E., Rizvi, B., Goldman, J. E. & Brickman, A. M. White matter changes in Alzheimer\u2019s disease: a focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 6, 22 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"1873_CR85","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jalz.2012.04.006","volume":"8","author":"A Moghekar","year":"2012","unstructured":"Moghekar, A. et al. Cerebral white matter disease is associated with Alzheimer pathology in a prospective cohort. Alzheimers Dement. 8, S71\u2013S77 (2012).","journal-title":"Alzheimers Dement."},{"key":"1873_CR86","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.jalz.2017.01.026","volume":"13","author":"A Roseborough","year":"2017","unstructured":"Roseborough, A., Ramirez, J., Black, S. E. & Edwards, J. D. Associations between amyloid \u03b2 and white matter hyperintensities: a systematic review. Alzheimers Dement. 13, 1154\u20131167 (2017).","journal-title":"Alzheimers Dement."},{"key":"1873_CR87","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archneurol.2012.1527","volume":"69","author":"AM Brickman","year":"2012","unstructured":"Brickman, A. M. et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. Arch. Neurol. 69, 1621\u20131627 (2012).","journal-title":"Arch. Neurol."},{"key":"1873_CR88","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/brain\/awy229","volume":"141","author":"M\u00c1 Araque Caballero","year":"2018","unstructured":"Araque Caballero, M. \u00c1. et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer\u2019s disease. Brain 141, 3065\u20133080 (2018).","journal-title":"Brain"},{"key":"1873_CR89","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaneurol.2014.667","volume":"71","author":"G Tosto","year":"2014","unstructured":"Tosto, G., Zimmerman, M. E., Carmichael, O. T., Brickman, A. M. & Alzheimer\u2019s Disease Neuroimaging Initiative. Predicting aggressive decline in mild cognitive impairment: the importance of white matter hyperintensities. JAMA Neurol. 71, 872\u2013877 (2014).","journal-title":"JAMA Neurol."},{"key":"1873_CR90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jalz.2014.07.155","volume":"10","author":"AM Brickman","year":"2014","unstructured":"Brickman, A. M. et al. APOE \u03b54 and risk for Alzheimer\u2019s disease: do regionally distributed white matter hyperintensities play a role? Alzheimers Dement. 10, 619\u2013629 (2014).","journal-title":"Alzheimers Dement."},{"key":"1873_CR91","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","volume":"79","author":"S Lee","year":"2016","unstructured":"Lee, S. et al. White matter hyperintensities are a core feature of Alzheimer\u2019s disease: evidence from the Dominantly Inherited Alzheimer Network. Ann. Neurol. 79, 929\u2013939 (2016).","journal-title":"Ann. Neurol."},{"key":"1873_CR92","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1016\/j.neurobiolaging.2015.08.026","volume":"36","author":"NS Ryan","year":"2015","unstructured":"Ryan, N. S. et al. Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer\u2019s disease. Neurobiol. Aging 36, 3140\u20133151 (2015).","journal-title":"Neurobiol. Aging"},{"key":"1873_CR93","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410190306","volume":"19","author":"A Brun","year":"1986","unstructured":"Brun, A. & Englund, E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann. Neurol. 19, 253\u2013262 (1986).","journal-title":"Ann. Neurol."},{"key":"1873_CR94","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2990.2007.00828.x","volume":"33","author":"JE Simpson","year":"2007","unstructured":"Simpson, J. E. et al. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol. Appl. Neurobiol. 33, 410\u2013419 (2007).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1873_CR95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/glia.22432","volume":"61","author":"G Behrendt","year":"2013","unstructured":"Behrendt, G. et al. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men. Glia 61, 273\u2013286 (2013).","journal-title":"Glia"},{"key":"1873_CR96","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1750-3639.2012.00595.x","volume":"22","author":"E Gagyi","year":"2012","unstructured":"Gagyi, E. et al. Decreased oligodendrocyte nuclear diameter in Alzheimer\u2019s disease and Lewy body dementia. Brain Pathol. 22, 803\u2013810 (2012).","journal-title":"Brain Pathol."},{"key":"1873_CR97","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/glia.21131","volume":"59","author":"MK Desai","year":"2011","unstructured":"Desai, M. K., Guercio, B. J., Narrow, W. C. & Bowers, W. J. An Alzheimer\u2019s disease-relevant presenilin-1 mutation augments amyloid-\u03b2-induced oligodendrocyte dysfunction. Glia 59, 627\u2013640 (2011).","journal-title":"Glia"},{"key":"1873_CR98","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.neuron.2021.05.012","volume":"109","author":"JF Chen","year":"2021","unstructured":"Chen, J. F. et al. Enhancing myelin renewal reverses cognitive dysfunction in a murine model of Alzheimer\u2019s disease. Neuron 109, 2292\u20132307 (2021).","journal-title":"Neuron"},{"key":"1873_CR99","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nn1008","volume":"6","author":"ER Sowell","year":"2003","unstructured":"Sowell, E. R. et al. Mapping cortical change across the human life span. Nat. Neurosci. 6, 309\u2013315 (2003).","journal-title":"Nat. Neurosci."},{"key":"1873_CR100","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-022-04554-y","volume":"604","author":"RAI Bethlehem","year":"2022","unstructured":"Bethlehem, R. A. I. et al. Brain charts for the human lifespan. Nature 604, 525\u2013533 (2022).","journal-title":"Nature"},{"key":"1873_CR101","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins, N. D. & Scheltens, P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat. Rev. Neurol. 11, 157\u2013165 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"1873_CR102","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41593-022-01042-4","volume":"25","author":"RM Brouwer","year":"2022","unstructured":"Brouwer, R. M. et al. Genetic variants associated with longitudinal changes in brain structure across the lifespan. Nat. Neurosci. 25, 421\u2013432 (2022).","journal-title":"Nat. Neurosci."},{"key":"1873_CR103","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/nn.4325","volume":"19","author":"S Safaiyan","year":"2016","unstructured":"Safaiyan, S. et al. Age-related myelin degradation burdens the clearance function of microglia during aging. Nat. Neurosci. 19, 995\u2013998 (2016).","journal-title":"Nat. Neurosci."},{"key":"1873_CR104","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1023\/A:1025731309829","volume":"31","author":"A Peters","year":"2002","unstructured":"Peters, A. The effects of normal aging on myelin and nerve fibers: a review. J. Neurocytol. 31, 581\u2013593 (2002).","journal-title":"J. Neurocytol."},{"key":"1873_CR105","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neurobiolaging.2003.03.001","volume":"25","author":"G Bartzokis","year":"2004","unstructured":"Bartzokis, G. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer\u2019s disease. Neurobiol. Aging 25, 5\u201318 (2004).","journal-title":"Neurobiol. Aging"},{"key":"1873_CR106","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cell.2013.07.037","volume":"154","author":"BH Toyama","year":"2013","unstructured":"Toyama, B. H. et al. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell 154, 971\u2013982 (2013).","journal-title":"Cell"},{"key":"1873_CR107","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06519-0","volume":"9","author":"EF Fornasiero","year":"2018","unstructured":"Fornasiero, E. F. et al. Precisely measured protein lifetimes in the mouse brain reveal differences across tissues and subcellular fractions. Nat. Commun. 9, 4230 (2018).","journal-title":"Nat. Commun."},{"key":"1873_CR108","volume":"2","author":"LE Collins-Praino","year":"2014","unstructured":"Collins-Praino, L. E. et al. Soluble amyloid \u03b2 levels are elevated in the white matter of Alzheimer\u2019s patients, independent of cortical plaque severity. Acta Neuropathol. Commun. 2, 83 (2014).","journal-title":"Acta Neuropathol. Commun."},{"key":"1873_CR109","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41586-023-06120-6","volume":"618","author":"C Depp","year":"2023","unstructured":"Depp, C. et al. Myelin dysfunction drives amyloid-\u03b2 deposition in models of Alzheimer\u2019s disease. Nature 618, 349\u2013357 (2023).","journal-title":"Nature"},{"key":"1873_CR110","doi-asserted-by":"crossref","unstructured":"Kaji, S. et al. Apolipoprotein E aggregation in microglia initiates Alzheimer\u2019s disease pathology by seeding \u03b2-amyloidosis. Immunity 57, 2651\u20132668 (2024).","DOI":"10.1016\/j.immuni.2024.09.014"},{"key":"1873_CR111","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1038\/s41593-023-01366-9","volume":"26","author":"E Sch\u00e4ffner","year":"2023","unstructured":"Sch\u00e4ffner, E. et al. Myelin insulation as a risk factor for axonal degeneration in autoimmune demyelinating disease. Nat. Neurosci. 26, 1218\u20131228 (2023).","journal-title":"Nat. Neurosci."},{"key":"1873_CR112","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42570-2","volume":"14","author":"J Groh","year":"2023","unstructured":"Groh, J. et al. Microglia-mediated demyelination protects against CD8+ T cell-driven axon degeneration in mice carrying PLP defects. Nat. Commun. 14, 6911 (2023).","journal-title":"Nat. Commun."},{"key":"1873_CR113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nn.4193","volume":"19","author":"M Traka","year":"2016","unstructured":"Traka, M., Podojil, J. R., McCarthy, D. P., Miller, S. D. & Popko, B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat. Neurosci. 19, 65\u201374 (2016).","journal-title":"Nat. Neurosci."},{"key":"1873_CR114","doi-asserted-by":"crossref","unstructured":"Kedia, S. et al. T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis. Nat. Neurosci. 27, 1468\u20131474 (2024).","DOI":"10.1038\/s41593-024-01682-8"},{"key":"1873_CR115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn.3357","volume":"16","author":"SH Kang","year":"2013","unstructured":"Kang, S. H. et al. Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat. Neurosci. 16, 571\u2013579 (2013).","journal-title":"Nat. Neurosci."},{"key":"1873_CR116","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/jnr.24672","volume":"98","author":"S Ferreira","year":"2020","unstructured":"Ferreira, S. et al. Amyloidosis is associated with thicker myelin and increased oligodendrogenesis in the adult mouse brain. J. Neurosci. Res. 98, 1905\u20131932 (2020).","journal-title":"J. Neurosci. Res."},{"key":"1873_CR117","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"1873_CR118","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jalz.2012.01.011","volume":"8","author":"H Braak","year":"2012","unstructured":"Braak, H. & Del Tredici, K. Alzheimer\u2019s disease: pathogenesis and prevention. Alzheimers Dement. 8, 227\u2013233 (2012).","journal-title":"Alzheimers Dement."},{"key":"1873_CR119","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nn.3390","volume":"16","author":"EG Hughes","year":"2013","unstructured":"Hughes, E. G., Kang, S. H., Fukaya, M. & Bergles, D. E. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat. Neurosci. 16, 668\u2013676 (2013).","journal-title":"Nat. Neurosci."},{"key":"1873_CR120","doi-asserted-by":"crossref","unstructured":"Micheva, K. D. et al. A large fraction of neocortical myelin ensheathes axons of local inhibitory neurons. eLife 5, e15784 (2016).","DOI":"10.7554\/eLife.15784"},{"key":"1873_CR121","doi-asserted-by":"crossref","first-page":"15927","DOI":"10.1073\/pnas.1010356107","volume":"107","author":"CE Collins","year":"2010","unstructured":"Collins, C. E., Airey, D. C., Young, N. A., Leitch, D. B. & Kaas, J. H. Neuron densities vary across and within cortical areas in primates. Proc. Natl Acad. Sci. USA 107, 15927\u201315932 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1873_CR122","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13195-022-01074-9","volume":"14","author":"A Rubinski","year":"2022","unstructured":"Rubinski, A. et al. Higher levels of myelin are associated with higher resistance against tau pathology in Alzheimer\u2019s disease. Alzheimers Res. Ther. 14, 139 (2022).","journal-title":"Alzheimers Res. Ther."},{"key":"1873_CR123","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/dneu.22518","volume":"78","author":"ME Bechler","year":"2018","unstructured":"Bechler, M. E., Swire, M. & Ffrench-Constant, C. Intrinsic and adaptive myelination\u2014a sequential mechanism for smart wiring in the brain. Dev. Neurobiol. 78, 68\u201379 (2018).","journal-title":"Dev. Neurobiol."},{"key":"1873_CR124","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41582-022-00737-3","volume":"18","author":"JK Knowles","year":"2022","unstructured":"Knowles, J. K., Batra, A., Xu, H. & Monje, M. Adaptive and maladaptive myelination in health and disease. Nat. Rev. Neurol. 18, 735\u2013746 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"1873_CR125","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nn1516","volume":"8","author":"SL Bengtsson","year":"2005","unstructured":"Bengtsson, S. L. et al. Extensive piano practicing has regionally specific effects on white matter development. Nat. Neurosci. 8, 1148\u20131150 (2005).","journal-title":"Nat. Neurosci."},{"key":"1873_CR126","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1126\/science.1254960","volume":"346","author":"IA McKenzie","year":"2014","unstructured":"McKenzie, I. A. et al. Motor skill learning requires active central myelination. Science 346, 318\u2013322 (2014).","journal-title":"Science"},{"key":"1873_CR127","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nn.4351","volume":"19","author":"L Xiao","year":"2016","unstructured":"Xiao, L. et al. Rapid production of new oligodendrocytes is required in the earliest stages of motor-skill learning. Nat. Neurosci. 19, 1210\u20131217 (2016).","journal-title":"Nat. Neurosci."},{"key":"1873_CR128","doi-asserted-by":"crossref","first-page":"19499","DOI":"10.1523\/JNEUROSCI.3048-13.2013","volume":"33","author":"C Sampaio-Baptista","year":"2013","unstructured":"Sampaio-Baptista, C. et al. Motor skill learning induces changes in white matter microstructure and myelination. J. Neurosci. 33, 19499\u201319503 (2013).","journal-title":"J. Neurosci."},{"key":"1873_CR129","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/nn.3263","volume":"15","author":"J Liu","year":"2012","unstructured":"Liu, J. et al. Impaired adult myelination in the prefrontal cortex of socially isolated mice. Nat. Neurosci. 15, 1621\u20131623 (2012).","journal-title":"Nat. Neurosci."},{"key":"1873_CR130","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1220845","volume":"337","author":"M Makinodan","year":"2012","unstructured":"Makinodan, M., Rosen, K. M., Ito, S. & Corfas, G. A critical period for social experience-dependent oligodendrocyte maturation and myelination. Science 337, 1357\u20131360 (2012).","journal-title":"Science"}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01873-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01873-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:23:19Z","timestamp":1741616599000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-01873-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":130,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-01873-x","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"20 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}